troglitazone has been researched along with Skin Neoplasms in 4 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mössner, R | 1 |
| Schulz, U | 1 |
| Krüger, U | 1 |
| Middel, P | 1 |
| Schinner, S | 1 |
| Füzesi, L | 1 |
| Neumann, C | 1 |
| Reich, K | 1 |
| He, G | 2 |
| Muga, S | 1 |
| Thuillier, P | 2 |
| Lubet, RA | 1 |
| Fischer, SM | 3 |
| Sung, YM | 1 |
| Digiovanni, J | 1 |
| Anchiraico, GJ | 1 |
| Nickel, KP | 1 |
| Maldve, RE | 1 |
| Gimenez-Conti, I | 1 |
| Muga, SJ | 1 |
| Liu, KL | 1 |
| Belury, MA | 1 |
4 other studies available for troglitazone and Skin Neoplasms
| Article | Year |
|---|---|
Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Chromans; Dose-Response Relationship, Drug; Fibrino | 2002 |
The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Cell Transformation, Neo | 2005 |
Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Growth Processes; Chromans; Enzy | 2006 |
Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion.
Topics: Animals; Anticarcinogenic Agents; Bezafibrate; Blotting, Western; Cell Differentiation; Cell Line; C | 2000 |